AIConfirmation hearing for Jayanta Bhattacharya to lead NIH

Health Care Costs and Drug PricingSenate Health, Education, Labor, and Pensions · 2025-03-05 · 119th Congress
The Senate HELP Committee met to consider the nomination of Dr. Begins at 0:16:49
Transcript
Highlights

Title

Confirmation hearing for Jayanta Bhattacharya to lead NIH

Purpose

The Senate HELP Committee met to consider the nomination of Dr. Jayanta Bhattacharya to be Director of the National Institutes of Health, examining his views on chronic disease research, scientific transparency, replicability, and vaccine safety, alongside sharp questioning about Trump administration and DOGE actions affecting NIH funding, staffing, and indirect cost rates. Members repeatedly pressed the nominee on grant freezes, the proposed 15% indirect cost cap, mass firings at NIH, and the influence of Elon Musk and Secretary Robert F. Kennedy Jr. over agency decisions. Begins at0:16:49

Who spoke

Chair Bill Cassidy (R-LA)0:16:49: Opened the hearing citing NIH's IDEA program funding ($509 in Louisiana referenced) and concern that NIH favors risk-averse incremental science0:18:15; later pressed Bhattacharya hard on whether NIH needs to further study a measles-autism link given exhaustive prior study and opportunity costs0:35:430:37:580:39:37.

Sen. Bernie Sanders (I-VT): Argued Americans pay far more for prescription drugs developed with NIH funding, citing a $111,000 average price for NIH-linked new treatments0:21:53 and a prostate cancer drug costing $179,000 in the US versus $18,000 in Japan0:22:35; said Elon Musk, not any nominee, effectively controls federal health agencies0:23:23; later pressed on drug pricing clauses and junk food advertising to kids0:41:130:44:30.

Sen. Pete Ricketts (R-NE)0:25:30: Introduced Bhattacharya, describing his advisory role during Nebraska's pandemic response and citing Nebraska's top-ranked Politico pandemic response score and 135 peer-reviewed publications by the nominee0:28:120:28:24.

Dr. Jayanta Bhattacharya, NIH Director nominee0:30:41: Laid out five priorities—chronic disease focus, replicable science, free speech culture, funding innovative research, and biosafety oversight0:32:08; said he does not believe there is a link between MMR vaccine and autism based on the literature0:36:380:38:48; committed to following the law on indirect cost caps0:59:47.

Sen. Susan Collins (R-ME)0:56:50: Said she is "strongly opposed" to the administration's arbitrary 15% indirect cost cap, noting it would violate appropriations law in place since 20170:58:380:59:08; cited 1,470 NIH-supported jobs in Maine in 20230:57:48; asked about continued support for the National Alzheimer's Project Act strategic plan1:01:21.

Sen. Patty Murray (D-WA)0:51:33: Said Trump and Musk are putting life-saving research at risk through grant freezes and mass firings0:51:56; got Bhattacharya to confirm Stanford's indirect cost rate is 55% and that a 15% cap would cost Stanford $160 million a year0:54:260:54:28.

Sen. Tammy Baldwin (D-WI)1:02:45: Revealed the administration halted $65 million in Alzheimer's funding, stopping 14 Alzheimer's disease research centers, which will run out of money by end of April1:03:43; pressed repeatedly on whether Bhattacharya agrees with cutting cancer and Alzheimer's research1:04:131:05:41.

Sen. Roger Marshall (R-KS)1:08:35: Argued NIH has wasted money chasing the amyloid hypothesis on Alzheimer's for 20 years1:09:02; asked about food-as-medicine research and distributing indirect costs to "flyover states"1:11:111:13:02.

Sen. Maggie Hassan (D-NH)1:14:17: Asked whether Bhattacharya would follow the law over a presidential directive to break it, calling his hedged answer "disappointing"1:14:37; cited a New Hampshire colon cancer patient, Christine, whose NIH-funded clinical trial care is at risk from funding freezes1:15:02; noted the retracted MMR-autism study has been refuted by seven studies across every continent1:17:59.

Sen. Tommy Tuberville (R-AL)1:19:45: Asked how Bhattacharya would build his team to root out waste and restore trust1:20:16; raised concerns about US-funded biolabs in Ukraine and a study on gender transitioning tied to two adolescent suicides1:22:041:23:21.

Sen. John Hickenlooper (D-CO)1:25:13: Asked how long it would take to build a new, transparent indirect cost system1:25:31; sought Bhattacharya's endorsement for cross-institute research on Down syndrome co-occurring disorders1:26:32; noted 99% of FDA-approved drugs over a decade had NIH-linked research1:27:28.

Sen. Ashley Moody (R-FL)1:30:52: Discussed Florida's pandemic response, saying Florida had a lower overall death rate than California1:34:15; asked about NIH prioritizing replication of studies1:35:29.

Sen. Andy Kim (D-NJ)1:36:27: Pressed on whether decentralized NIH decision-making would resist White House pressure to fund specific universities1:38:25; cited a Kennedy quote about giving infectious disease research "a break for about eight years"1:39:33; asked about the Richardson Waiver1:41:17.

Sen. Jim Banks (R-IN)1:47:31: Praised Bhattacharya's Great Barrington Declaration stance against lockdowns, noting Fauci called it "total nonsense"1:43:54; asked what pandemic public health data now shows1:44:20.

Sen. Lisa Blunt Rochester (D-DE)1:47:01: Cited $360 million Alzheimer's cost figures for 2024 and 11 million unpaid caregivers1:48:21; asked about canceled diversity-in-aging-research programs including MARC and the NIH Summer Internship Program1:49:28.

Sen. Josh Hawley (R-MO)1:52:34: Asked whether Bhattacharya would reinstate the Trump-era ban on aborted fetal tissue in NIH research, which he committed to1:52:581:53:24; raised concerns about NIH conflicts of interest with pharmaceutical companies and the "proximal origin" COVID paper1:56:30.

Sen. Angela Alsobrooks (D-MD)1:58:06: Asked whether Bhattacharya believes it's ever appropriate to retaliate against scientists over their research, which he denied supporting1:58:351:58:52; questioned him about a study he co-authored on racial disparities in heart transplant survival and potential DEI "watchlists"2:00:52.

Sen. Jon Husted (R-OH)2:03:45: Framed health care inflation as the top cost driver in the economy and asked how NIH could rethink chronic disease research2:04:34.

Sen. Ed Markey (D-MA)2:08:56: Read accounts from Massachusetts researchers on depression, cancer, and Alzheimer's research stalled by funding freezes2:09:25; cited letters showing NIH grants terminated for including LGBTQ populations, submitted for the record2:10:402:11:28; pressed Bhattacharya to commit to opposing MAGA-ideology-based funding cuts2:12:44.

Key moments

Sanders said Americans pay over 10 times what other countries pay for the same NIH-developed drugs, citing a prostate cancer drug costing $179,000 in the US versus $18,000 in Japan, and argued real authority over health agencies rests with Elon Musk, not the NIH director0:22:350:23:23.

Cassidy repeatedly pressed Bhattacharya on whether NIH should fund further research into a measles vaccine-autism link, arguing the opportunity cost of "replowing" settled ground diverts resources from chronic disease; Bhattacharya said he does not believe there is a link but would not fully rule out further study0:36:380:38:480:39:37.

Murray got Bhattacharya to confirm Stanford's indirect cost rate is 55%, meaning a proposed 15% cap would cost Stanford $160 million per year; Bhattacharya said he didn't know where the "55% tip" money goes but called for transparency rather than defending the cap0:54:260:54:470:55:07.

Collins stated flatly that the administration's 15% indirect cost cap is illegal, violating appropriations language in place since 2017, and noted a judge has already stayed the order0:58:380:59:36.

Baldwin revealed the administration halted $65 million in Alzheimer's research funding, stopping 14 Alzheimer's disease research centers that will run out of money by the end of April, and repeatedly asked Bhattacharya to state a position; he demurred, saying he lacked access to the information1:03:431:05:07.

Hassan asked whether Bhattacharya would follow the law over a presidential directive to break it; he answered "I don't believe the president would ever ask me to break the law," which Hassan called "disappointing" and said "strains credulity"1:14:371:14:42.

Banks and Bhattacharya discussed the Great Barrington Declaration, with Banks noting Fauci called it "total nonsense" and Rochelle Walensky called it "wrong and unsafe," while Bhattacharya said Florida had a lower COVID death rate than California and Sweden had lower death rates than Norway and Germany despite less lockdown1:43:541:45:25.

Markey submitted letters for the record showing NIH terminated grants studying Alzheimer's caregiving and primary-care mental health because the studies "explicitly included LGBTQ people," and pressed Bhattacharya to commit to reinstating such funding; he declined to commit directly, saying he would "look carefully into it"2:10:402:13:042:13:18.

Hawley secured Bhattacharya's commitment to reinstate the Trump-era policy prohibiting NIH funding of research using aborted fetal tissue, following the lead of Secretary Kennedy1:52:581:53:24.

Cassidy noted for the record near the hearing's midpoint that NIH funding "has not been cancelled," only that meetings to allocate funding have been delayed, pushing back on characterizations from Democratic senators1:08:24.

Metadata

Official titleHearings to examine the nomination of Jayanta Bhattacharya, of California, to be Director of the National Institutes of Health, Department of Health and Human Services.
CommitteeSenate Health, Education, Labor, and Pensions
Chamber / CongressSenate · 119th Congress
Date2025-03-05
TypeMeeting
Witnesses
(none listed in event metadata)
Videosenate-isvp
Transcript399 caption blocks · 17,929 words · 2:20:09 runtime
EventCongress.gov 336682